DrugPatentWatch Database Preview
Email this page to a colleagueSee Plans and Pricing
« Back to Dashboard
Mitoquinone is an investigational drug.
There have been 6 clinical trials for Mitoquinone. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2010.
The most common disease conditions in clinical trials are Sclerosis, Multiple Sclerosis, and Fatigue. The leading clinical trial sponsors are Antipodean Pharmaceuticals, Inc., VA Office of Research and Development, and Oregon Health and Science University.
Recent Clinical Trials for Mitoquinone
|MitoQ for Fatigue in Multiple Sclerosis (MS)||VA Office of Research and Development||Phase 1/Phase 2|
|MitoQ on Fatigue in Multiple Sclerosis||MitoQ Ltd||Phase 1/Phase 2|
|MitoQ on Fatigue in Multiple Sclerosis||Oregon Health and Science University||Phase 1/Phase 2|